Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iqvia Holdings Inc (NY: IQV )

190.73 -3.15 (-1.62%)
Official Closing Price Updated: 7:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iqvia Holdings Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Why Are NRx Pharma Shares Moving Higher On Tuesday Premarket?
Iqvia Holdings Inc (NYSE: IQV) has collaborated with NRx Pharmaceuticals Inc (NASDAQ: NRXP) to provide pharmacovigilance services and medical information... 
Via Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... 
Via Benzinga
Exposures COVID-19
IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment
From IQVIA
Via Business Wire
Where IQVIA Holdings Stands With Analysts
Within the last quarter, IQVIA Holdings (NYSE:IQV) has observed the following ... 
Via Benzinga
Recap: IQVIA Q2 Earnings
Shares of IQVIA Holdings (NYSE:IQV) fell 0.2% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 80.51% over the past... 
Via Benzinga
IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World Data
From IQVIA
Via Business Wire
IQVIA CFO, Ron Bruehlman, to Speak at the Baird 2021 Global Healthcare Conference on September 14, 2021
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Launches New A.I.-Powered MI Contact Center For Life Sciences
From IQVIA
Via Business Wire
IQVIA Holdings inc (IQV) Q2 2021 Earnings Call Transcript
IQV earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Scheduled For July 27, 2021
Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million.... 
Via Benzinga
Where IQVIA Holdings Stands With Analysts
IQVIA Holdings (NYSE:IQV) has observed the following analyst... 
Via Benzinga
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week... 
Via Benzinga
PerkinElmer Stock Earns 83 Relative Strength Rating; Buys Lifescience Firm BioLegend
One key metric to look for in a stock is an 80-plus Relative Strength Rating. PerkinElmer stock hit that mark, jumping to 83 on Tuesday. 
Via Investor's Business Daily
Exposures COVID-19
IQVIA Reports Second-Quarter 2021 Results and Raises Full-Year 2021 Guidance
From IQVIA Holdings Inc.
Via Business Wire
Consumer Health Apps and Digital Health Tools Proliferate, Improving Quality and Health Outcomes for Patients, Says New Report from IQVIA Institute
From IQVIA
Via Business Wire
PerkinElmer Stock Sees Improved Technical Ratings; Still Within Buy Zone
Perkinelmer shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
IQVIA to Announce Second-Quarter 2021 Results on July 27, 2021
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Launches the Clinical Data Analytics Suite (CDAS) to Enable Smarter, Faster Clinical Trials
From IQVIA
Via Business Wire
Q² Solutions Announces Significant Expansion of Laboratory Operations in Scotland, UK
From IQVIA
Via Business Wire
Q2 Solutions and Tasso Collaborate to Provide Unique Solutions for Patients to Accelerate Adoption of Decentralized Clinical Trials
From IQVIA
Via Business Wire
Global Oncology Innovation Continues Despite Pandemic; Global R&D Pipeline Reached 3,500 New Drugs in 2020, up 75% from 2015, Says New Report from the IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
ASML, Google Lead 5 Stocks That You Can Buy Now
ASML and Google stock, which are on several IBD stock lists, are among several leaders flashing at least early entries. 
Via Investor's Business Daily
IQVIA CFO, Ron Bruehlman, to Speak at the William Blair Growth Stock Conference on June 2, 2021
From IQVIA
Via Business Wire
Avantor Stock Showing Improved Relative Strength After 350%-Plus Run In Little More Than A Year
In terms of fundamentals, Avantor posted 106% EPS growth last quarter, to 35 cents a share. In the three preceding quarters its EPS grew 19%, 60% and 53%. 
Via Investor's Business Daily
Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
Medical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes
Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes. 
Via Investor's Business Daily
How To Trade These 7 Healthcare Stocks and ETF Says 2ndSkiesForex's Chris Capre
The Benzinga Global Small Cap Conference on May 13 featured presentations from publicly-traded companies and educational segments for investors. Among the featured... 
Via Benzinga
U.S. District Court Issues Favorable Decision for IQVIA Against Veeva
From IQVIA
Via Business Wire
Charles River Labs Joins Elite List Of Stocks With 95-Plus Composite Rating
Charles River Labs' Accumulation/Distribution Rating of A, on an A+ to E scale, shows heavy buying by institutional investors over the last 13 weeks. 
Via Investor's Business Daily
IQVIA’s Orchestrated Customer Engagement (OCE) Solution Chosen to Support the Commercial Launch of Novel ADHD Drug
From IQVIA
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.